The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib

The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib was developed by the experts of the Russian Association of Endocrinologists and the Russian Society of Clinical Oncology. The consensus contains recommendation o...

Full description

Saved in:
Bibliographic Details
Main Authors: Natalya V. Mazurina, Elena V. Artamonova, Maria F. Beloyartseva, Ekaterina I. Volkova, Inna P. Ganshina, Ekaterina A. Troshina, Sergey A. Tjulandin, Viacheslav A. Chubenko
Format: article
Language:RU
Published: IP Habib O.N. 2021
Subjects:
Online Access:https://doaj.org/article/95b6d9b471d74d51ad5bf1e4d91f076f
Tags: Add Tag
No Tags, Be the first to tag this record!